SVCM
ZURA icon

Saturn V Capital Management’s Zura Bio ZURA Stock Holding History

Saturn V Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
2,101,119
+1,361,159
+184% +$6.48M 1.78% 15
2026
Q1 		$4.4M Buy
+739,960
New +$4.47M 0.8% 19

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Saturn V Capital Management's ZURA Position: Q2 2026 in Review

Saturn V Capital Management increased its Zura Bio (ZURA) stake by 184% in Q2 2026, buying an estimated $6.48M and bringing the position to 2,101,119 shares worth $12.4M. The position accounts for 1.78% of the portfolio, ranked #15.

Saturn V Capital Management first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Saturn V Capital Management held 2,101,119 shares of Zura Bio worth $12.4M as of Q2 2026.
  • Saturn V Capital Management bought 1,361,159 Zura Bio shares in Q2 2026, an estimated $6.48M.
  • Zura Bio made up 1.78% of Saturn V Capital Management's portfolio in Q2 2026, its #15 holding.
  • Saturn V Capital Management first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Saturn V Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.